Your browser doesn't support javascript.
loading
[Efficacy of Arsenic Trioxide Combined with ATRA and Chemotherapy for Relapsed Acute Promyelocytic Leukemia Patients].
Li, Yan; Liu, Kai-Qi; Gong, Ben-Fa; Wang, Ying; Wei, Hui; Lin, Dong; Liu, Bing-Cheng; Zhou, Chun-Lin; Wei, Shu-Ning; Zhang, Guang-Ji; Liu, Yun-Tao; Gong, Xiao-Yuan; Wang, Jian-Xiang; Mi, Ying-Chang.
Affiliation
  • Li Y; Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College,State Key Laboratory of Experimental Hematology, Tianjin 300020, China,National Clinical Research Center for Blood Diseases, Tianjin 300020, China.
  • Liu KQ; Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College,State Key Laboratory of Experimental Hematology, Tianjin 300020, China,National Clinical Research Center for Blood Diseases, Tianjin 300020, China.
  • Gong BF; Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College,State Key Laboratory of Experimental Hematology, Tianjin 300020, China,National Clinical Research Center for Blood Diseases, Tianjin 300020, China.
  • Wang Y; Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College,State Key Laboratory of Experimental Hematology, Tianjin 300020, China,National Clinical Research Center for Blood Diseases, Tianjin 300020, China.
  • Wei H; Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College,State Key Laboratory of Experimental Hematology, Tianjin 300020, China,National Clinical Research Center for Blood Diseases, Tianjin 300020, China.
  • Lin D; Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College,State Key Laboratory of Experimental Hematology, Tianjin 300020, China,National Clinical Research Center for Blood Diseases, Tianjin 300020, China.
  • Liu BC; Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College,State Key Laboratory of Experimental Hematology, Tianjin 300020, China,National Clinical Research Center for Blood Diseases, Tianjin 300020, China.
  • Zhou CL; Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College,State Key Laboratory of Experimental Hematology, Tianjin 300020, China,National Clinical Research Center for Blood Diseases, Tianjin 300020, China.
  • Wei SN; Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College,State Key Laboratory of Experimental Hematology, Tianjin 300020, China,National Clinical Research Center for Blood Diseases, Tianjin 300020, China.
  • Zhang GJ; Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College,State Key Laboratory of Experimental Hematology, Tianjin 300020, China,National Clinical Research Center for Blood Diseases, Tianjin 300020, China.
  • Liu YT; Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College,State Key Laboratory of Experimental Hematology, Tianjin 300020, China,National Clinical Research Center for Blood Diseases, Tianjin 300020, China.
  • Gong XY; Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College,State Key Laboratory of Experimental Hematology, Tianjin 300020, China,National Clinical Research Center for Blood Diseases, Tianjin 300020, China.
  • Wang JX; Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College,State Key Laboratory of Experimental Hematology, Tianjin 300020, China,National Clinical Research Center for Blood Diseases, Tianjin 300020, China.
  • Mi YC; Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College,State Key Laboratory of Experimental Hematology, Tianjin 300020, China,National Clinical Research Center for Blood Diseases, Tianjin 300020, China,Tianjin Clinical Research Cente
Zhongguo Shi Yan Xue Ye Xue Za Zhi ; 28(1): 1-6, 2020 Feb.
Article in Zh | MEDLINE | ID: mdl-32027244

Full text: 1 Database: MEDLINE Main subject: Arsenicals / Leukemia, Promyelocytic, Acute Limits: Humans Language: Zh Year: 2020 Type: Article

Full text: 1 Database: MEDLINE Main subject: Arsenicals / Leukemia, Promyelocytic, Acute Limits: Humans Language: Zh Year: 2020 Type: Article